Phacilitate home
  • When: 06-07 December, 2026
  • Where: Crowne Plaza Riyadh RDC
  • Search
Exhibit with us Register your interest
SEARCH
Loading
Search
We're sorry, but we couldn't find any results that match your search criteria. Please try again with different keywords or filters.
Loading
09:00 AM
  1. Opening Ceremony & Welcoming Address
    5 mins
09:05 AM
  1. A New Global Hub: Saudi Arabia's Biotechnology Play for Vision 2030
    40 mins
    By 2040, Saudi Arabia will position itself as the leading global biotechnology hub, marking a beginning of a transformational journey for the biotechnology landscape. With the National Biotechnology S ...
09:45 AM
  1. Exhibition Time Hall Open
    495 mins
  2. Scaling MSC Therapies: 4 Global Markets, 1 Proven Path to MSC Commercialization
    30 mins
    Moving an allogeneic cell therapy from breakthrough research at the bench to a multi-center, global Phase 3 clinical trial is incredibly complex. If you don't have a proven roadmap for international c ...
  3. Ecosystem Gap Analysis Roundtables
    60 mins
10:15 AM
  1. Coffee Break
    30 mins
10:45 AM
  1. Unique Populations, Faster Breakthroughs: Unlocking Global Opportunities for Advanced Therapy Trials
    30 mins
    As the race to develop next-generation cell and gene therapies accelerates, one of the biggest bottlenecks remains patient identification and trial recruitment. Increasingly, sponsors are looking beyo ...
  2. A Global Outlook on ATMP Investment Landscape: What Has Happened and Where it is Going
    30 mins
11:15 AM
  1. Advancing Rare Disease & Orphan Therapy Innovation in the Middle East
    30 mins
    The Middle East is rapidly becoming a hub for rare disease and orphan therapy innovation, driven by high prevalence of inherited disorders, ambitious national genomics programs, and a growing life sci ...
  2. Accelerating & Incubating Early-Stage Biotech - Global Focus
    30 mins
11:45 AM
  1. Dhuhr Prayer & Coffee Break
    30 mins
12:15 PM
  1. Patients Can't Wait: Building Regional Manufacturing for Global Advanced Therapy Access
    30 mins
    Today, most cell and gene therapies are manufactured in a small number of locations in the US and Europe, creating global supply bottlenecks that delay patient access and increase costs. Across the wo ...
  2. Building GCCs Sustainable Cell & Gene Therapy Ecosystem: From Research to Real-World Impact
    30 mins
    Building a fully integrated cell and gene therapy ecosystem is one of the most complex challenges facing emerging biotech markets today. But translating academic research into scalable, sustainable in ...
12:45 PM
  1. Theraputic Developer Case Study: Scaling Accessible Cell Therapies
    30 mins
    In this session, learn how early stage biotechs can design scalable manufacturing platforms from day 1 with the ultimate goal of driving therapy costs under $20000 and discover key lessons and mistake ...
  2. Stop Leading with Data, Start Leading with Impact: How to Secure Saudi Funding for Your Biotech
    30 mins
    In the Kingdom, investment decisions are increasingly shaped by long-term national priorities aligned with Saudi Vision 2030 and the National Biotechnology Strategy. Investors are not only evaluating ...
01:15 PM
  1. Lunch
    75 mins
02:30 PM
  1. The EU Biotech Act Meets Vision 2030: Bridging the $34 Billion Advanced Therapy Divide
    30 mins
    The global advanced therapy market is highly fragmented. While Europe possesses world-class scientific research, complex regulatory bottlenecks have historically choked commercialization'causing the E ...
  2. Attracting Global Biotech Manufacturing to Saudi Arabia: What Will It Take?
    30 mins
    What would convince equipment providers, GMP modular builders, and platform developers to establish local operations? A discussion on incentives, partnerships, and long-term strategic positioning.
03:00 PM
  1. Asr Prayer Break
    30 mins
  2. From Vision to Venture: Building High-Multiplier Life Science Portfolios
    30 mins
    Discover how investors can create meaningful returns while supporting Saudi Arabia's biotech ambitions. This session dives into early-stage portfolio strategies, risk management, and how to select ven ...
03:30 PM
  1. The China Advanced Therapy Opportunity.
    30 mins
    China has become one of the fastest-growing cell and gene therapy markets in the world, with a rapidly expanding pipeline, significant investment, and a growing number of clinical trials. However, reg ...
  2. How Global Biotech Can Enter KSA: Practical Roadmap
    30 mins
    ' Step by step pathway for regulatory, clinical, manufacturing, commercial entry ' What documentation, partnerships, and timelines global biotechs should expect ' Practical do's/don'ts based on typica ...
04:00 PM
  1. Is US Biotech Still the Center of Gravity? Or Are Global Markets Rewriting the Rules?
    30 mins
    For decades, the US has been the undisputed engine of biotech innovation'dominating venture capital flows, clinical development, and the commercialization of breakthrough therapies. But as costs rise ...
  2. Manufacturing Tenant Attraction Strategy
    30 mins
    What types of global tenants KSA should attract (CDMOs, modality specialists, platforms) What tenants require: incentives, infrastructure, labor, demand guarantee Lessons from Singapore, Ireland, Kore ...
04:30 PM
  1. Closing Ceremony - The Patient's Story
    30 mins
09:00 AM
  1. Day 2 Opening Remarks
    5 mins
09:05 AM
  1. Faster Than the West? Rethinking Regulatory Pathways for Advanced Therapies
    40 mins
    For years, regulation has been viewed as one of the biggest barriers to bringing advanced therapies to patients'slow approval timelines, rigid frameworks, and fragmented global pathways. But across se ...
09:45 AM
  1. Exhibition Time Hall Open
    315 mins
  2. From Lab to 2,400 Patients: How Saudi's First National CGT Hub is Transforming Therapy Access
    30 mins
    Saudi Arabia is taking a bold step in advanced therapies with the Kingdom's first national cell and gene therapy hub at King Faisal Specialist Hospital. Once operational, the facility will deliver 2,4 ...
  3. The In Vivo Revolution: Scaling Next-Gen CAR-T
    30 mins
10:15 AM
  1. The $1.2M Bottleneck: Why Big Pharma Is Betting on Automated IDMOs
    30 mins
    The science behind advanced cell therapies has been proven, but commercial sustainability is currently hitting a massive wall: manufacturing. Traditional production is heavily dependent on manual inte ...
  2. Beyond Oncology: CNS with Next-Gen CAR?A Cell Therapies
    30 mins
10:45 AM
  1. Unlocking the Middle East for Clinical Trials: The Role of CROs, Regulators and Hospitals
    30 mins
    Countries such as Saudi Arabia and the United Arab Emirates are rapidly emerging as credible destinations for global clinical research, supported by national strategies like Saudi Vision 2030 and UAE ...
  2. The Cell-Free Advantage: MSC Exosomes
    30 mins
11:15 AM
  1. Scaling Skills, Scaling Science: Creating a Biotech Talent Revolution
    30 mins
    As the cell and gene therapy industry scales from breakthrough science to global manufacturing and commercial delivery, one challenge continues to loom large: talent. From bioprocess engineers and reg ...
  2. Unleashing the Untapped Market: Non?Viral Gene Editing
    30 mins
11:45 AM
  1. Dhuhr Prayer & Coffee Break
    30 mins
12:15 PM
  1. The Health Data Opportunity: How to Leverage Digital Capability Building for Clinical Trials, Real World Evidence Generation, and Drug Development
    30 mins
  2. The Mega-Blockbuster Era: Next-Gen CAR?Ts
    30 mins
12:45 PM
  1. Challenges and Opportunities of AI in Drug Discovery for MENA-Specific Diseases
    30 mins
    AI has the potential to transform cell and gene therapy manufacturing ' from optimising bioprocessing and quality control to reducing costs and scaling production. For the Middle East, this presents a ...
  2. The Dual-Engine Strategy: Balancing CAR?T Revenues
    30 mins
01:15 PM
  1. One Global Ecosystem: Connecting APAC, the US, Europe, and the Middle East for the Future of Advanced Therapies
    75 mins
    Advanced therapies don't succeed in isolation. They thrive within interconnected ecosystems that span discovery, translational science, manufacturing, regulation, and patient access. This session expl ...
  2. Lunch
    75 mins
  3. Your Trial Isn't Failing - Your System Is: Fixing the Oncology Trial Bottleneck
    75 mins
02:30 PM
  1. From Bench to IDMO: Scaling Next-Gen ATTR Antibodies
    30 mins
Search